phenoxybenzamine has been researched along with Pseudotumor Cerebri in 1 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Pseudotumor Cerebri: A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duncan, AW | 1 |
Tibballs, J | 1 |
Sutherland, SK | 1 |
1 other study available for phenoxybenzamine and Pseudotumor Cerebri
Article | Year |
---|---|
Effects of Sydney funnel-web spider envenomation in monkeys, and their clinical implications.
Topics: Acidosis; Acute Disease; Animals; Arrhythmias, Cardiac; Catecholamines; Cats; Dogs; Fever; Hypertens | 1980 |